0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pediatric Obesity Management Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-23F13510
Home | Market Reports | Health| Pharmacy
Global Pediatric Obesity Management Market Research Report 2023
BUY CHAPTERS

Global Pediatric Obesity Management Market Research Report 2025

Code: QYRE-Auto-23F13510
Report
May 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pediatric Obesity Management Market Size

Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe.

Pediatric Obesity Management Market

Pediatric Obesity Management Market

The global market for Pediatric Obesity Management was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. And China and the United States accounted for 44% of total sports spending.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pediatric Obesity Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Obesity Management.
The Pediatric Obesity Management market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Obesity Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Obesity Management manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pediatric Obesity Management Market Report

Report Metric Details
Report Name Pediatric Obesity Management Market
Accounted market size in 2022 750 billion
Base Year 2022
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, F.Hoffmann-La Roche, GlaxoSmithKline, AstraZeneca,, Herbalife, ApolloEndosurgery, Ethicon, Inc., Takeda Pharmaceutical Company, VIVUS, Currax Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pediatric Obesity Management manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pediatric Obesity Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Pediatric Obesity Management Market share by region?

Ans: And China and the United States accounted for 44% of total sports spending.

Who are the main players in the Pediatric Obesity Management Market report?

Ans: The main players in the Pediatric Obesity Management Market are Pfizer, F.Hoffmann-La Roche, GlaxoSmithKline, AstraZeneca,, Herbalife, ApolloEndosurgery, Ethicon, Inc., Takeda Pharmaceutical Company, VIVUS, Currax Pharmaceuticals

What are the Application segmentation covered in the Pediatric Obesity Management Market report?

Ans: The Applications covered in the Pediatric Obesity Management Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Pediatric Obesity Management Market report?

Ans: The Types covered in the Pediatric Obesity Management Market report are Lorcaserin, Liraglutide, Phentermine, Setmelanotide, Others

Recommended Reports

Pediatric Health Solutions

Weight Loss & Control

Obesity Treatments & Devices

1 Pediatric Obesity Management Market Overview
1.1 Product Definition
1.2 Pediatric Obesity Management by Type
1.2.1 Global Pediatric Obesity Management Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lorcaserin
1.2.3 Liraglutide
1.2.4 Phentermine
1.2.5 Setmelanotide
1.2.6 Others
1.3 Pediatric Obesity Management by Application
1.3.1 Global Pediatric Obesity Management Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Pediatric Obesity Management Market Size Estimates and Forecasts
1.4.1 Global Pediatric Obesity Management Revenue 2020-2031
1.4.2 Global Pediatric Obesity Management Sales 2020-2031
1.4.3 Global Pediatric Obesity Management Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pediatric Obesity Management Market Competition by Manufacturers
2.1 Global Pediatric Obesity Management Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pediatric Obesity Management Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pediatric Obesity Management Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pediatric Obesity Management, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pediatric Obesity Management, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Obesity Management, Product Type & Application
2.7 Global Key Manufacturers of Pediatric Obesity Management, Date of Enter into This Industry
2.8 Global Pediatric Obesity Management Market Competitive Situation and Trends
2.8.1 Global Pediatric Obesity Management Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pediatric Obesity Management Players Market Share by Revenue
2.8.3 Global Pediatric Obesity Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pediatric Obesity Management Market Scenario by Region
3.1 Global Pediatric Obesity Management Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pediatric Obesity Management Sales by Region: 2020-2031
3.2.1 Global Pediatric Obesity Management Sales by Region: 2020-2025
3.2.2 Global Pediatric Obesity Management Sales by Region: 2026-2031
3.3 Global Pediatric Obesity Management Revenue by Region: 2020-2031
3.3.1 Global Pediatric Obesity Management Revenue by Region: 2020-2025
3.3.2 Global Pediatric Obesity Management Revenue by Region: 2026-2031
3.4 North America Pediatric Obesity Management Market Facts & Figures by Country
3.4.1 North America Pediatric Obesity Management Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pediatric Obesity Management Sales by Country (2020-2031)
3.4.3 North America Pediatric Obesity Management Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pediatric Obesity Management Market Facts & Figures by Country
3.5.1 Europe Pediatric Obesity Management Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pediatric Obesity Management Sales by Country (2020-2031)
3.5.3 Europe Pediatric Obesity Management Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Obesity Management Market Facts & Figures by Region
3.6.1 Asia Pacific Pediatric Obesity Management Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pediatric Obesity Management Sales by Region (2020-2031)
3.6.3 Asia Pacific Pediatric Obesity Management Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pediatric Obesity Management Market Facts & Figures by Country
3.7.1 Latin America Pediatric Obesity Management Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pediatric Obesity Management Sales by Country (2020-2031)
3.7.3 Latin America Pediatric Obesity Management Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pediatric Obesity Management Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Obesity Management Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pediatric Obesity Management Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pediatric Obesity Management Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pediatric Obesity Management Sales by Type (2020-2031)
4.1.1 Global Pediatric Obesity Management Sales by Type (2020-2025)
4.1.2 Global Pediatric Obesity Management Sales by Type (2026-2031)
4.1.3 Global Pediatric Obesity Management Sales Market Share by Type (2020-2031)
4.2 Global Pediatric Obesity Management Revenue by Type (2020-2031)
4.2.1 Global Pediatric Obesity Management Revenue by Type (2020-2025)
4.2.2 Global Pediatric Obesity Management Revenue by Type (2026-2031)
4.2.3 Global Pediatric Obesity Management Revenue Market Share by Type (2020-2031)
4.3 Global Pediatric Obesity Management Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pediatric Obesity Management Sales by Application (2020-2031)
5.1.1 Global Pediatric Obesity Management Sales by Application (2020-2025)
5.1.2 Global Pediatric Obesity Management Sales by Application (2026-2031)
5.1.3 Global Pediatric Obesity Management Sales Market Share by Application (2020-2031)
5.2 Global Pediatric Obesity Management Revenue by Application (2020-2031)
5.2.1 Global Pediatric Obesity Management Revenue by Application (2020-2025)
5.2.2 Global Pediatric Obesity Management Revenue by Application (2026-2031)
5.2.3 Global Pediatric Obesity Management Revenue Market Share by Application (2020-2031)
5.3 Global Pediatric Obesity Management Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pediatric Obesity Management Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Pediatric Obesity Management Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 F.Hoffmann-La Roche
6.2.1 F.Hoffmann-La Roche Company Information
6.2.2 F.Hoffmann-La Roche Description and Business Overview
6.2.3 F.Hoffmann-La Roche Pediatric Obesity Management Sales, Revenue and Gross Margin (2020-2025)
6.2.4 F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolio
6.2.5 F.Hoffmann-La Roche Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Pediatric Obesity Management Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Pediatric Obesity Management Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 AstraZeneca,
6.4.1 AstraZeneca, Company Information
6.4.2 AstraZeneca, Description and Business Overview
6.4.3 AstraZeneca, Pediatric Obesity Management Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca, Pediatric Obesity Management Product Portfolio
6.4.5 AstraZeneca, Recent Developments/Updates
6.5 Herbalife
6.5.1 Herbalife Company Information
6.5.2 Herbalife Description and Business Overview
6.5.3 Herbalife Pediatric Obesity Management Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Herbalife Pediatric Obesity Management Product Portfolio
6.5.5 Herbalife Recent Developments/Updates
6.6 ApolloEndosurgery
6.6.1 ApolloEndosurgery Company Information
6.6.2 ApolloEndosurgery Description and Business Overview
6.6.3 ApolloEndosurgery Pediatric Obesity Management Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ApolloEndosurgery Pediatric Obesity Management Product Portfolio
6.6.5 ApolloEndosurgery Recent Developments/Updates
6.7 Ethicon, Inc.
6.7.1 Ethicon, Inc. Company Information
6.7.2 Ethicon, Inc. Description and Business Overview
6.7.3 Ethicon, Inc. Pediatric Obesity Management Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ethicon, Inc. Pediatric Obesity Management Product Portfolio
6.7.5 Ethicon, Inc. Recent Developments/Updates
6.8 Takeda Pharmaceutical Company
6.8.1 Takeda Pharmaceutical Company Company Information
6.8.2 Takeda Pharmaceutical Company Description and Business Overview
6.8.3 Takeda Pharmaceutical Company Pediatric Obesity Management Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolio
6.8.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.9 VIVUS
6.9.1 VIVUS Company Information
6.9.2 VIVUS Description and Business Overview
6.9.3 VIVUS Pediatric Obesity Management Sales, Revenue and Gross Margin (2020-2025)
6.9.4 VIVUS Pediatric Obesity Management Product Portfolio
6.9.5 VIVUS Recent Developments/Updates
6.10 Currax Pharmaceuticals
6.10.1 Currax Pharmaceuticals Company Information
6.10.2 Currax Pharmaceuticals Description and Business Overview
6.10.3 Currax Pharmaceuticals Pediatric Obesity Management Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Currax Pharmaceuticals Pediatric Obesity Management Product Portfolio
6.10.5 Currax Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Obesity Management Industry Chain Analysis
7.2 Pediatric Obesity Management Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Obesity Management Production Mode & Process Analysis
7.4 Pediatric Obesity Management Sales and Marketing
7.4.1 Pediatric Obesity Management Sales Channels
7.4.2 Pediatric Obesity Management Distributors
7.5 Pediatric Obesity Management Customer Analysis
8 Pediatric Obesity Management Market Dynamics
8.1 Pediatric Obesity Management Industry Trends
8.2 Pediatric Obesity Management Market Drivers
8.3 Pediatric Obesity Management Market Challenges
8.4 Pediatric Obesity Management Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pediatric Obesity Management Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pediatric Obesity Management Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pediatric Obesity Management Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pediatric Obesity Management Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pediatric Obesity Management Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pediatric Obesity Management Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pediatric Obesity Management Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pediatric Obesity Management Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pediatric Obesity Management, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pediatric Obesity Management, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pediatric Obesity Management, Product Type & Application
 Table 12. Global Key Manufacturers of Pediatric Obesity Management, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pediatric Obesity Management by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Obesity Management as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pediatric Obesity Management Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pediatric Obesity Management Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pediatric Obesity Management Sales Market Share by Region (2020-2025)
 Table 19. Global Pediatric Obesity Management Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pediatric Obesity Management Sales Market Share by Region (2026-2031)
 Table 21. Global Pediatric Obesity Management Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pediatric Obesity Management Revenue Market Share by Region (2020-2025)
 Table 23. Global Pediatric Obesity Management Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pediatric Obesity Management Revenue Market Share by Region (2026-2031)
 Table 25. North America Pediatric Obesity Management Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pediatric Obesity Management Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pediatric Obesity Management Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pediatric Obesity Management Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pediatric Obesity Management Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pediatric Obesity Management Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pediatric Obesity Management Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pediatric Obesity Management Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pediatric Obesity Management Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pediatric Obesity Management Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pediatric Obesity Management Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pediatric Obesity Management Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pediatric Obesity Management Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pediatric Obesity Management Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pediatric Obesity Management Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pediatric Obesity Management Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pediatric Obesity Management Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pediatric Obesity Management Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pediatric Obesity Management Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pediatric Obesity Management Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pediatric Obesity Management Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pediatric Obesity Management Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pediatric Obesity Management Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pediatric Obesity Management Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pediatric Obesity Management Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pediatric Obesity Management Sales (K Units) by Type (2020-2025)
 Table 51. Global Pediatric Obesity Management Sales (K Units) by Type (2026-2031)
 Table 52. Global Pediatric Obesity Management Sales Market Share by Type (2020-2025)
 Table 53. Global Pediatric Obesity Management Sales Market Share by Type (2026-2031)
 Table 54. Global Pediatric Obesity Management Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pediatric Obesity Management Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pediatric Obesity Management Revenue Market Share by Type (2020-2025)
 Table 57. Global Pediatric Obesity Management Revenue Market Share by Type (2026-2031)
 Table 58. Global Pediatric Obesity Management Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pediatric Obesity Management Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pediatric Obesity Management Sales (K Units) by Application (2020-2025)
 Table 61. Global Pediatric Obesity Management Sales (K Units) by Application (2026-2031)
 Table 62. Global Pediatric Obesity Management Sales Market Share by Application (2020-2025)
 Table 63. Global Pediatric Obesity Management Sales Market Share by Application (2026-2031)
 Table 64. Global Pediatric Obesity Management Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pediatric Obesity Management Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pediatric Obesity Management Revenue Market Share by Application (2020-2025)
 Table 67. Global Pediatric Obesity Management Revenue Market Share by Application (2026-2031)
 Table 68. Global Pediatric Obesity Management Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pediatric Obesity Management Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Pediatric Obesity Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Pediatric Obesity Management Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. F.Hoffmann-La Roche Company Information
 Table 76. F.Hoffmann-La Roche Description and Business Overview
 Table 77. F.Hoffmann-La Roche Pediatric Obesity Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. F.Hoffmann-La Roche Pediatric Obesity Management Product
 Table 79. F.Hoffmann-La Roche Recent Developments/Updates
 Table 80. GlaxoSmithKline Company Information
 Table 81. GlaxoSmithKline Description and Business Overview
 Table 82. GlaxoSmithKline Pediatric Obesity Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline Pediatric Obesity Management Product
 Table 84. GlaxoSmithKline Recent Developments/Updates
 Table 85. AstraZeneca, Company Information
 Table 86. AstraZeneca, Description and Business Overview
 Table 87. AstraZeneca, Pediatric Obesity Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AstraZeneca, Pediatric Obesity Management Product
 Table 89. AstraZeneca, Recent Developments/Updates
 Table 90. Herbalife Company Information
 Table 91. Herbalife Description and Business Overview
 Table 92. Herbalife Pediatric Obesity Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Herbalife Pediatric Obesity Management Product
 Table 94. Herbalife Recent Developments/Updates
 Table 95. ApolloEndosurgery Company Information
 Table 96. ApolloEndosurgery Description and Business Overview
 Table 97. ApolloEndosurgery Pediatric Obesity Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. ApolloEndosurgery Pediatric Obesity Management Product
 Table 99. ApolloEndosurgery Recent Developments/Updates
 Table 100. Ethicon, Inc. Company Information
 Table 101. Ethicon, Inc. Description and Business Overview
 Table 102. Ethicon, Inc. Pediatric Obesity Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Ethicon, Inc. Pediatric Obesity Management Product
 Table 104. Ethicon, Inc. Recent Developments/Updates
 Table 105. Takeda Pharmaceutical Company Company Information
 Table 106. Takeda Pharmaceutical Company Description and Business Overview
 Table 107. Takeda Pharmaceutical Company Pediatric Obesity Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Takeda Pharmaceutical Company Pediatric Obesity Management Product
 Table 109. Takeda Pharmaceutical Company Recent Developments/Updates
 Table 110. VIVUS Company Information
 Table 111. VIVUS Description and Business Overview
 Table 112. VIVUS Pediatric Obesity Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. VIVUS Pediatric Obesity Management Product
 Table 114. VIVUS Recent Developments/Updates
 Table 115. Currax Pharmaceuticals Company Information
 Table 116. Currax Pharmaceuticals Description and Business Overview
 Table 117. Currax Pharmaceuticals Pediatric Obesity Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Currax Pharmaceuticals Pediatric Obesity Management Product
 Table 119. Currax Pharmaceuticals Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Pediatric Obesity Management Distributors List
 Table 123. Pediatric Obesity Management Customers List
 Table 124. Pediatric Obesity Management Market Trends
 Table 125. Pediatric Obesity Management Market Drivers
 Table 126. Pediatric Obesity Management Market Challenges
 Table 127. Pediatric Obesity Management Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pediatric Obesity Management
 Figure 2. Global Pediatric Obesity Management Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pediatric Obesity Management Market Share by Type: 2024 & 2031
 Figure 4. Lorcaserin Product Picture
 Figure 5. Liraglutide Product Picture
 Figure 6. Phentermine Product Picture
 Figure 7. Setmelanotide Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Pediatric Obesity Management Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Pediatric Obesity Management Market Share by Application: 2024 & 2031
 Figure 11. Hospital Pharmacies
 Figure 12. Retail Pharmacies
 Figure 13. Online Pharmacies
 Figure 14. Global Pediatric Obesity Management Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pediatric Obesity Management Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Pediatric Obesity Management Sales (2020-2031) & (K Units)
 Figure 17. Global Pediatric Obesity Management Average Price (US$/Unit) & (2020-2031)
 Figure 18. Pediatric Obesity Management Report Years Considered
 Figure 19. Pediatric Obesity Management Sales Share by Manufacturers in 2024
 Figure 20. Global Pediatric Obesity Management Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Pediatric Obesity Management Players: Market Share by Revenue in Pediatric Obesity Management in 2024
 Figure 22. Pediatric Obesity Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Pediatric Obesity Management Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Pediatric Obesity Management Sales Market Share by Country (2020-2031)
 Figure 25. North America Pediatric Obesity Management Revenue Market Share by Country (2020-2031)
 Figure 26. United States Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Pediatric Obesity Management Sales Market Share by Country (2020-2031)
 Figure 29. Europe Pediatric Obesity Management Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Pediatric Obesity Management Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Pediatric Obesity Management Revenue Market Share by Region (2020-2031)
 Figure 37. China Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Pediatric Obesity Management Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Pediatric Obesity Management Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Pediatric Obesity Management Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Pediatric Obesity Management Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Pediatric Obesity Management Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Pediatric Obesity Management by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Pediatric Obesity Management by Type (2020-2031)
 Figure 56. Global Pediatric Obesity Management Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Pediatric Obesity Management by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Pediatric Obesity Management by Application (2020-2031)
 Figure 59. Global Pediatric Obesity Management Price (US$/Unit) by Application (2020-2031)
 Figure 60. Pediatric Obesity Management Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart